Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by P Jayakumar
Reliance, Adani, L&T among 50-plus corporates vying for India’s green hydrogen opportunity
India’s green hydrogen ambitions are beginning to translate into a business pipeline spanning electrolyser manufacturing, hydrogen production, green ammonia, refinery supplies and exports, with more than 50 companies vying for a share of the emerging market, according to industry sources. The government has awarded 15 companies 3 GW a year of electrolyser manufacturing capacity and incentivised green hydrogen production through the National Green Hydrogen Mission.
Coal gasification to gain momentum as Adani, NTPC among big investors
India’s coal gasification programme is gaining momentum, with the Centre’s ₹37,500-crore incentive scheme drawing interest from large private and public-sector companies and setting the stage for investments of ₹2.5–3 lakh crore across the value chain.
India requires an additional 2.6 billion sq. ft of healthcare real estate by 2035, says report
India will need an additional 2.6 billion sq. ft of healthcare real estate by 2035, driven by the need for nearly 2.9 million additional hospital beds, says a report. India currently has approximately 1.6 hospital beds per 1,000 people, significantly below the global average of 3.3 per 1,000. To close this capacity gap, the country’s total healthcare real estate footprint would need to expand substantially from an estimated 2.1 billion sq.
Adani Group begins building 2 lakh homes in Dharavi; plans to invest $4-5 billion in first phase
The Adani Group has started construction of the massive Dharavi township, one of the largest urban rejuvenation projects in the world, by performing the bhoomi poojan at the 22-acre Matunga railway site in Mumbai this week. The group will spend over $4-5 billion in the initial phase, which is estimated to take about seven years. Go Ad-Free Sign up for Fortune India's ad-free experience Enjoy uninterrupted access to premium content and insights.
Biocon settles patent dispute with Genentech over breast cancer drug
Biocon Ltd has entered into a global settlement and license agreement with US based biotech major Genentech for its drug Pebrilzo, a biosimilar or copycat version of Genentech's breast cancer drug Perjeta (Pertuzumab). Biocon and Genentech executed the patent settlement agreement to resolve all pending disputes between the companies, including in the U.S., Canada, and other jurisdictions.
MS Dhoni launches combined Maharashtra diagnostics operations of Neuberg and NM Medical
Serial entrepreneur G.S.K. Velu-promoted Neuberg Diagnostics is consolidating its Maharashtra operations with Dr Nilesh Shah-led Mumbai-based NM Medical to create an integrated diagnostics network combining advanced pathology, radiology, genomics and preventive healthcare. Former India cricket captain MS Dhoni unveiled the platform in Mumbai on October 3, along with Atlas, Neuberg’s new longevity and wellness initiative.
India’s green hydrogen makers begin to get firm export orders from Japan and Europe Original
India’s green hydrogen story is beginning to move beyond government incentives and project announcements, with binding international commercial offtake agreements emerging for Indian producers of green ammonia and green methanol. The first major export commitments are being secured by companies such as ACME Group, AM Green and Larsen & Toubro’s L&T Energy GreenTech, with Japan and Europe emerging as the first large overseas markets.
India's Top 100 Billionaires 2026: Sudhir and Samir Mehta, pharma’s power players
TORRENT GROUP, one of India’s leading diversified conglomerates, has evolved far beyond its pharmaceutical roots. One of the country’s oldest pharma players, the group now has presence across power generation and distribution, transmission and storage, city gas, electricals, diagnostics, and sports as well. With revenues exceeding ₹50,000 crore and an estimated valuation of ₹3 lakh crore, the Ahmedabad-based Torrent has grown into a formidable force across sectors.
KP Group plans next phase of big growth in renewables by FY32
Renewable energy major KP Group, which has three listed companies—KPI Green Energy, KP Energy and KP Green Engineering—has reset its growth ambitions, targeting 10 GW of owned power generation, 10 GW of third-party EPC execution and 10 GWh of integrated battery manufacturing capacity, besides diversifications into newer areas related to renewables by 2032. Go Ad-Free Sign up for Fortune India's ad-free experience Enjoy uninterrupted access to premium content and insights.
Haldia Petrochemicals’ ₹6,000 crore phenol-acetone project to reduce India's import dependence
Haldia Petrochemicals (HPL) is investing around ₹6,000 crore in a new phenol and acetone manufacturing facility through its 100% subsidiary AdPerma, which will significantly reduce India's import dependence on these key molecules used in industrial applications. India’s phenol demand is estimated at 650,000–700,000 tonnes, against domestic production of only about 330,000 tonnes.
India's Top 100 Billionaires 2026: Gautam Adani rises above the tempest to triumph
Gautam Adani, chairman, Adani Group. Credits: Getty Images FY26 WAS A defining year for the Adani Group and its 64-year-old chairman, Gautam Adani. Beyond the scale of its financial and operational performance, the year marked another significant step in Adani’s comeback amid extraordinary scrutiny.
Coal gasification plans gain momentum as Adani, NTPC enter fray
India’s coal gasification programme is gaining momentum, with large corporates such as Adani Enterprises and NTPC entering the first round of the government’s ₹37,500 crore scheme to promote surface coal and lignite gasification projects. Seven applications have been submitted in the first round, according to the Ministry of Coal. NTPC has proposed a synthetic natural gas (SNG) project, while Adani Enterprises has submitted three urea projects.
Race to 500 GW: India’s renewable energy titans battle for leadership
AI Generated by Fortune India Race to 500 GW: India’s renewable energy titans battle for leadershipAugust 6, 2026, 15:28 IST Loading AI Hub... Disclaimer : Certain content on this page, including summaries, timelines, FAQs, glossaries, highlights, insights, and other supplementary informational features, maybe generated or assisted by artificial intelligence tools.
Floating solar gets a major push as Cabinet clears ₹5,070-crore Surya Sarovar scheme
India’s push to diversify its renewable energy portfolio received a significant boost with the Union cabinet approving the Pradhan Mantri Surya Sarovar Yojana (PM-SSY), a ₹5,070-crore scheme to accelerate floating solar photovoltaic (FSPV) projects integrated with energy storage systems (ESS). The scheme seeks to develop 5,000 MW of floating solar capacity with co-located battery storage having a minimum storage duration of two hours, or 10,000 MWh of storage capacity.
GLP-1 drugs set to transform India’s metabolic healthcare
For decades, diabetes treatment in India largely revolved around oral medicines and insulin. Now, a new class of medicines known as GLP-1 receptor agonists is beginning to redefine the management of diabetes and a broader spectrum of metabolic disorders—from obesity and fatty liver disease to cardiovascular risk. The transformation began with the expiry of the primary compound patent for Novo Nordisk’s semaglutide, marketed globally as Ozempic and Wegovy.
Gold demand in India surges by 50% to ₹198,100 crores in Q2, 2026
AI Generated by Fortune India Gold demand in India surges by 50% to ₹198,100 crores in Q2, 2026July 30, 2026, 17:16 IST Loading AI Hub... Disclaimer : Certain content on this page, including summaries, timelines, FAQs, glossaries, highlights, insights, and other supplementary informational features, maybe generated or assisted by artificial intelligence tools.
Eris Lifesciences bets on insulin, GLP-1s, and biologics to power next phase of growth; eyes 25% insulin market share
AI Generated by Fortune India Eris Lifesciences bets on insulin, GLP-1s, and biologics to power next phase of growth; eyes 25% insulin market shareJuly 29, 2026, 18:50 IST Loading AI Hub... Disclaimer : Certain content on this page, including summaries, timelines, FAQs, glossaries, highlights, insights, and other supplementary informational features, maybe generated or assisted by artificial intelligence tools.
How Trivitron's G.S.K. Velu became the accidental healthcare emperor
G.S.K. Velu, chairman & MD, Trivitron Group of Companies. Credits: Nishikant Gamre THE LIVES OF TWO Tamilians — Arokiaswamy Velumani and G.S.K. Velu — who pioneered and transformed organised diagnostics healthcare in India, have striking similarities. Velumani, born to poor parents in a village near Coimbatore, travelled 25 kilometres to attend colleges that offered affordable education. He had no money for hostel accommodation or commuting.
India close to developing drug for sickle cell disease as Zydus-ICMR candidate enters phase III trials
India's efforts to develop an effective treatment for the neglected disease sickle cell anaemia have received a significant boost, with Zydus Lifesciences' drug candidate, Desidustat, advancing to Phase III clinical trials in collaboration with the Indian Council of Medical Research (ICMR). Sickle cell disease is particularly prevalent among tribal populations, and despite affecting millions of Indians, treatment options have remained limited for decades.
Organon shareholders approve merger with Sun Pharma
Sun Pharmaceutical Industries on Friday announced that the stockholders of Organon & Co. have approved the proposals in connection with the previously announced merger transaction under which Organon is expected to become a wholly owned subsidiary of Sun Pharmaceutical Holdings USA, Inc., an indirect wholly owned subsidiary of Sun Pharma. The shareholder approval marks an important milestone towards completion of the proposed transaction.
IEA sees global electricity demand growing by over 3.6% in 2026; India demand growth at 7%
While recent disruptions to global natural gas markets due to the war in the Middle East have pushed up electricity generation costs in many regions, global electricity demand will grow by 3.6% in 2026 and by a further 3.8% in 2027 – up from 3% growth in 2025. In India, demand growth is forecast to rebound strongly to 7% following weather-related weakness in 2025.
India’s geothermal energy dreams gather steam
India’s long-awaited geothermal energy ambitions have taken a significant step forward with the successful completion of two deep geothermal wells by Oil and Natural Gas Corporation (ONGC) at Puga Valley in Ladakh, opening up fresh possibilities for clean, dependable and round-the-clock renewable power.
India’s power discoms are healthier than before, but subsidy dependence remains a major challenge
India’s state-owned electricity distribution companies (discoms) have significantly strengthened their balance sheets over the past five years, thanks to unprecedented financial support from state and central governments. However, deep-rooted structural reforms remain essential to put the sector on a sustainable path, reduce dependence on subsidies and fund the modernisation needed to support India’s rapidly expanding power system, according to a new study by S&P Global.
India-UK CETA to drive 8.7% growth in pharma exports to UK in FY27: Pharmexcil
AI Generated by Fortune India India-UK CETA to drive 8.7% growth in pharma exports to UK in FY27: PharmexcilJuly 16, 2026, 19:25 IST Loading AI Hub... Disclaimer : Certain content on this page, including summaries, timelines, FAQs, glossaries, highlights, insights, and other supplementary informational features, maybe generated or assisted by artificial intelligence tools.
A new refining capacity addition cycle begins for India's petrochem sector
The dedication of the HPCL Rajasthan Refinery Limited’s (HRRL) integrated refinery-cum-petrochemical complex at Pachpadra in Rajasthan’s Balotra district by Prime Minister Narendra Modi on July 7 has kick-started a new wave of refining capacity expansion in India and marks a defining moment in the country’s energy security ambitions. It is also the first greenfield refinery to be commissioned in India in over a decade.
What India can learn from the Hormuz crisis
Crude oil tankers, bulk carriers, and vessels sit anchored around Qaboos Port on June 22 in Muscat, Oman. Credits: Getty Images AFTER NEARLY four months of uncertainty and disruption, the war clouds over the Middle East are finally beginning to lift. Peace discussions between the U.S. and Iran are progressing, and the Strait of Hormuz — through which nearly 20% of the world’s oil and liquefied natural gas trade passes — is gradually reopening.
Adani: The art of braving ‘extraordinary scrutiny’ and growing with resilience
AI Generated by Fortune India Adani: The art of braving ‘extraordinary scrutiny’ and growing with resilienceJune 28, 2026, 09:15 IST Loading AI Hub... Disclaimer : Certain content on this page, including summaries, timelines, FAQs, glossaries, highlights, insights, and other supplementary informational features, maybe generated or assisted by artificial intelligence tools.
Kerala Budget charts a roadmap for a ‘New Kerala’ with port-led economy, infra boost, and knowledge-led development
AI Generated by Fortune India Kerala Budget charts a roadmap for a ‘New Kerala’ with port-led economy, infra boost, and knowledge-led developmentJune 19, 2026, 15:56 IST Loading AI Hub... Disclaimer : Certain content on this page, including summaries, timelines, FAQs, glossaries, highlights, insights, and other supplementary informational features, maybe generated or assisted by artificial intelligence tools.
Transforming a wasteland into the world’s largest renewable energy city in Khavda
Perched barely 10 km from the Pakistan border, Khavda remains one of the most remote and little-known villages in Gujarat’s vast Kutch district—a windswept landscape of barren earth with brown mud and useless bush vegetation, endless horizons, and scattered small hamlets that have learnt to coexist with one of the country’s harshest environments. Distance defines life in Khavda.
Indian corporates set to build ISRO’s ‘Bahubali’ rockets
AI Generated by Fortune India Indian corporates set to build ISRO’s ‘Bahubali’ rocketsJune 10, 2026, 11:58 IST Loading AI Hub... Disclaimer : Certain content on this page, including summaries, timelines, FAQs, glossaries, highlights, insights, and other supplementary informational features, maybe generated or assisted by artificial intelligence tools.
Fuel crisis blues: How price hikes are triggering pressure on the economy
AS THE THREE-MONTH-OLD West Asia conflict continues to put pressure on global economies, India has started feeling the impact, despite handling the fuel supply crisis better than many other nations.
Record profits, but daily losses—the fuel pricing dilemma for government-owned OMCs
India’s public sector oil marketing companies (OMCs) are incurring losses of around ₹500 crore every day, despite four rounds of petrol and diesel price hikes carried out within just ten days in May. The cumulative increase of about ₹7.5 per litre was implemented to partly offset the impact of soaring global crude oil prices triggered by the continuing West Asia conflict.
Inox Clean Energy acquires Vena Energy's 6 GW portfolio; 10th acquisition in 10 months
Inox Clean Energy Limited (Inox Clean), part of the INOXGFL Group, has acquired Vena Energy India’s (Vena) 6 gigawatt (GW) renewable energy portfolio, to take its overall operating portfolio to 4 GW with an additional 12 GW developmental pipeline. It is the 10th strategic acquisition by Inox Clean Energy in the last 10 months.
Trump tariffs fail to dent US appetite for Indian shrimp as seafood exports hit record $8.46 billion
India's seafood export sector has achieved a historic milestone, recording its highest-ever export earnings of $8.46 billion (₹73,890.46 crore) in FY25-26, underscoring the resilience of the country's marine products industry amid global trade uncertainties, tariff pressures, and geopolitical disruptions.
Fujifilm’s Nura brings AI-driven preventive health screening to India; plans 100 centres globally by 2030
Can doctors directly assess plaque in blood vessels to better predict heart attack risk, rather than relying solely on traditional lipid profiles? Can liver enlargement be evaluated beyond a physical exam and a standard CT scan? Increasingly, the answer to both is yes—thanks to advances in imaging, analytics, and artificial intelligence that are reshaping preventive healthcare.
We are not looking at healthcare for making profits, says Jaslok Hospital Chairman Vinod P. Chanrai
Jaslok Hospital, one of the top iconic Mumbai hospitals and one of the oldest charitable corporate hospitals in India, is undergoing a ₹400 crore full renovation. Run by a charitable trust, the 350-bedded hospital was started 53 years ago by businessman and philanthropist Seth Lokoomal Chanrai. Vinod P.
Jaslok Hospital’s ₹400-crore makeover: Mumbai’s iconic charitable hospital renews itself without shutting down
One of Mumbai’s most iconic healthcare institutions, Jaslok Hospital, is undergoing a massive ₹300-400 crore renovation programme aimed at completely modernising the over five-decade-old facility while continuing normal operations. The 350-bed hospital, founded by businessman-philanthropist Lokoomal Chanrai and renowned cardiologist Dr Shantilal Mehta, was inaugurated in 1973 by former Prime Minister Indira Gandhi.
Floating solar with BESS opens a new renewable energy engine for India’s energy security ambitions
India's renewable energy growth plans will soon get a new thrust area - floating solar - as the expenditure finance committee (EFC) under the finance ministry has approved a proposed ₹5,500 crore scheme focused on floating solar projects integrated with battery energy storage systems (BESS). The move is primarily aimed at reducing the demand for huge tracts of land required for renewable energy projects.
India’s data centre boom triggers high-stakes race among corporates
The Yotta data centre in Greater Noida. Credits: Sanjay Rawat THE 15-STOREYED AI data centre of Yotta in Panvel, Navi Mumbai, hums round-the-clock, with the heat of artificial intelligence (AI). Inside the towering facility, the constant whirr of GPU processors from NVIDIA and CPUs from AMD and Intel fills the air.
India’s coal gasification ambitions gain momentum; technology and coal quality challenges remain
India’s search for new energy streams to ensure energy security has gathered momentum with the launch of a ₹37,500-crore scheme aimed at accelerating the country’s coal and lignite gasification programme, primarily as an import-substitution initiative for key products such as LNG, urea, ammonia, methanol and related chemicals.
Tata Power’s green pivot gathers pace
Tata Power , India’s largest vertically integrated power company, is charting a smooth transition towards becoming a fully clean and green energy producer by 2045, steadily reducing its dependence on thermal power generation. Currently, nearly 53% of Tata Power’s operational capacity of 16.7 GW comes from thermal power, which was over 80% a decade ago.
The next 10 years will be about high-value innovation, says Kiran Mazumdar-Shaw
Are you happy with the progress Biocon has made so far? Why should I not be happy? I am very happy, very proud, because everything we have done, we have done systematically, with a very strategic thought process, and it has worked. It is now paying back dividends for us. I did very well with enzymes, and, to think about it, I had developed the enzymes for bioethanol in the ’80s.
Succession and the road ahead at Biocon
Kiran Mazumdar-Shaw, executive chairperson, Biocon and Syngene International Ltd, and Shreehas Tambe, MD & CEO, Biocon. Credits: Selvaprakash Lakshmanan IF I FOUND A POT OF GOLD, I would give it to my aunt for her company to make new medicine for very bad diseases,” wrote a six-year-old Eric. It was a child’s drawing — a simple cutout of a pot brimming with gold coins, words scrawled on the pot with earnest clarity. Years later, that message would stay with his aunt, Kiran Mazumdar-Shaw.
L&T’s Lakshya 31 to ride on core growth and technology-led new businesses
Engineering and technology major Larsen & Toubro (L&T) has unveiled its next five-year strategic roadmap — Lakshya 31 — aimed at making the organisation future-ready through accelerated investments in AI, digital technologies, data centres, green energy, industrial electronics and semiconductor technologies, while consolidating its leadership in infrastructure, energy and high-tech manufacturing.
Electricity demand to rise by 5.0-5.5% in 2026-27: ICRA
Demand from the agricultural and household sectors and below-expected rainfall may cause power demand in India to rise by 5.0-5.5% in 2026-27, compared with a tepid 1% rise in 2025-26. A potential El Niño effect this summer, which may lead to reduced rainfall during the monsoon, along with high demand from industries and emerging sources such as electric vehicles and data centres, will drive electricity demand during the financial year, predicts rating agency ICRA.
West Asia crisis: Strong response, but challenges persist ahead in petrochem space
Around 20% of the world’s oil and LNG passes via the Strait of Hormuz. Credits: Getty Images AS THE WEST ASIA crisis enters its third month and the Strait of Hormuz — through which 20% of the world’s oil and LNG passes — remains shut, triggering an unprecedented hike in oil prices across the globe, India is one of the rare Asian countries that has braved the crisis well.
Shanghvi’s audacious bet with $11.75-billion Sun-Organon deal
WHEN DILIP SHANGHVI started his pharmaceutical venture in 1983, few could have anticipated that Sun Pharmaceutical Industries would emerge as India’s largest drugmaker, clocking over ₹50,000 crore in annual revenues by FY25. In an era where business leaders chase diversification to build sprawling conglomerates, Shanghvi has taken a markedly different path — staying rooted in the business he understands best.
Fortune India Exclusive: Kiran Mazumdar-Shaw charts Biocon’s next phase; identifies niece Claire Mazumdar as successor
Kiran Mazumdar-Shaw , founder and chairperson of Biocon , has set in motion a clear succession plan as she prepares the four-decade-old group and India’s largest biotechnology enterprise for its next phase of growth—one driven by advanced biotechnology innovation and artificial intelligence. Her chosen successor is her niece, Claire Mazumdar, a 37-year-old biotech specialist who currently serves as founder-CEO of Bicara Therapeutics, a NASDAQ-listed company incubated by Biocon.
UDF set to end Pinarayi Vijayan’s 10-year rule in Kerala
The Congress-led United Democratic Front (UDF) has stormed back to power in Kerala, likely winning over 100 of the 140 Assembly seats and bringing an end to the decade-long rule of Pinarayi Vijayan and the Left Democratic Front (LDF), according to the latest available trends. A strong wave of anti-incumbency, coupled with voter fatigue against a leadership seen as overly centralised, played a decisive role in the outcome.
Sun Pharma’s Organon acquisition: Dilip Shanghvi’s high stakes bet for big growth
What prompted India’s largest pharmaceuticals company, Sun Pharmaceutical Industries—operating smoothly with revenues of over $6.2 billion in FY25 and a strong balance sheet with $3.1 billion in cash—to go for a risky acquisition of almost same-sized Organon, with $6.2 billion revenues in FY25, debt of $8.6 billion and a de-growing company, in an all‑cash transaction for nearly $12 billion?
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with P
Contact P, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack